Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'letter' OR with Authors including 'letter' OR with Abstract including 'letter' OR with Keywords including 'letter'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Balestrieri A, Fontanari ... Prime esperienze con LSD 25 nell'epilessia "psicomotoria" Atti Ist. Veneto Sci... 1956
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
van der Horst L The way of working with "model" psychoses Advanc. psychosom. M... 1960
Eisner BG, Melvin JD Letter to the Editor on the use of Alpha Feedback in a Therapeutic, Pr... Unknown 1965
Editorial Pros and Con Regarding LSD (Letters to Editor from: Frank Fremont-Smit... New Eng. J. Med. 1966
JR MacLean LSD Experiments (Letters to the Editor) Med. World News 1966
Fremont-Smith F, Altschul... Pros and con regarding LSD. (Letters to the Editor) New Engl. J. Med. 1966
Ungerleider JT, Tisher DD LSD Today Medical Digest 1967
Zsigmond EK Letters to the editor of clinical workshop. Anesthetic Considerations ... Anesthesiology 1968
Parsons GE Letter: Street drug analysis commended J Am Pharm Assoc 1974
Andrew Weil Letters from Andrew : The Green and the White Journal of Psychedel... 1975
Andrew Weil Letters From Andrew Weil: The Love Drug Journal of Psychedel... 1976
Torre E, Pavesi M, Torre ... Azione Dell'LSD-25 Sulle Colinesterasi Del Cervello Di Ratto Boll. Soc. It. Biol.... 1979
McLellan, AT, Woody GE, O... Psychiatric Illness in Drug Abusers New Engl. J. Med. 1980
Davis WM LSD or DOB? Am J Psychiatry 1982
Weaver KEC Letters to the Editor: LSD and Schizophrenia Arch. Gen. Psychiatr... 1984
Riedlinger JE The scheduling of MDMA: a pharmacist's perspective J Psychoactive Drugs 1985
Brown C, Osterloh J Multiple severe complications from recreational ingestion of MDMA ('Ec... JAMA 1987
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Verebey K, Alrazi J, Jaff... The complications of 'ecstasy' (MDMA) JAMA 1988
Martinez, J.A. Letters To The Editor Journal of Psychoact... 1988
Arnold WN Vincent van Gogh and the Thujone Connection JAMA 1988
Laverty R, Logan BJ Ecstasy abuse N Z Med J 1989
Hanson GR, Sonsalla P, Le... Effects of amphetamine analogs on central nervous system neuropeptide ... NIDA Res Monogr 1989
Kahn, EJ Jungle Botanist New Yorker Magazine 1992
Riedlinger TJ Wasson's alternative candidates for soma J Psychoactive Drugs 1993
Gledhill JA, Moore DF, Be... Subarachnoid haemorrhage associated with MDMA abuse [letter] J Neurol Neurosurg P... 1993
McCann UD, Ricaurte GA On the neurotoxicity of MDMA and related amphetamine derivatives [lett... J Clin Psychopharmac... 1995
Wilkins B Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake (... BMJ 1996
Cook TM Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake. ... BMJ 1996
Matthai SM, Davidson DC, ... Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted i... BMJ 1996
Johnston E, Sanxter S, Cr... Newletter of the Association for Hawai'ian 'Awa Association for Hawa... 1998
Johnston E, Ooka J, Cross... Newletter of the Association for Hawai'ian 'Awa Association for Hawa... 1998
Perrine DM Hallucinogens and Obsessive-Compulsive Disorder Am J Psychiatry 1999
Borg GJ More about parkinsonism after taking ecstasy N Engl J Med 1999
Baggott M, Mendelson J, J... More about parkinsonism after taking ecstasy N Engl J Med 1999
Polifka JE, Shepard TH Studies of the fetal effects of dextromethorphan in ovo Teratology 1999
McFee RB, Mofenson HC, Ca... Dextromethorphan: Another 'Ecstasy'? Arch Fam Med 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Boyer EW, Quang L, Woolf ... Dextromethorphan and Ecstasy Pills JAMA 2001
Aghajanian GK, Liebermann... Caveat Emptor: Editors Beware Neuropsychopharmacol... 2001
De Letter EA, Coopman VA,... One fatal and seven non-fatal cases of 4-methylthioamphetamine 4-MTA i... Int J Legal Med 2001
Decaestecker T, De Letter... Fatal 4-MTA intoxication: development of a liquid chromatographic-tand... J Anal Toxicol 2001
Leshner AI What should the public be told about the risks of Ecstasy? JAMA 2002
De Letter EA, Clauwaert K... CASE REPORT: Distribution Study of 3,4-Methylenedioxymethamphetamine a... Journal of Analytica... 2002
De Letter EA, Clauwaert K... Distribution study of 3,4-methylenedioxymethamphetamine and 3,4-methyl... J Anal Toxicol 2002
Boire RG What should the public be told about the risks of Ecstasy? (2) JAMA 2002
Vastag B What should the public be told about the risks of Ecstasy? (3) JAMA 2002
Fox HC, McLean A, Turner ... Neuropsychological evidence of a relatively selective profile of tempo... Psychopharmacology (... 2002
De Letter EA, Belpaire FM... Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA,... Int J Legal Med 2002
De Letter EA, Clauwaert K... Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA,... Int J Legal Med 2002
De Letter EA, Clauwaert K... Post-mortem redistribution of 3,4-methylenedioxymethamphetamine MDMA, ... Int J Legal Med 2002
De Letter EA, Belpaire FM... Post-mortem redistribution of 3,4-methylenedioxymethamphetamine MDMA, ... Int J Legal Med 2002
Green AR, McGregor IS On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT dep... Psychopharmacology (... 2002
De Letter EA, Espeel MF, ... Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... Int J Legal Med 2003
Forrest AR Dataset on deaths related to taking ecstasy looks incomplete BMJ 2003
Hirst MM Kat, the Law and the Somalian Who Got Away PlantLife 2003
Kuniyoshi SM, Jankovic J MDMA and Parkinsonism N Engl J Med 2003
Dams R, De Letter EA, Mor... Fatality due to combined use of the designer drugs MDMA and PMA: a dis... J Anal Toxicol 2003
Sumnall HR, Jerome L, Dob... Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, ... Psychopharmacology (... 2004
Parrott AC, Rodgers J, Bu... The reality of psychomotor problems, and the possibility of Parkinson'... Psychopharmacology (... 2004
Wareing M, Murphy PN, Fis... Visuospatial memory impairments in users of MDMA ('ecstasy') Psychopharmacology (... 2004
de la Torre R, Farre M, M... Response to Sprague and Nichols: Contribution of metabolic activation ... Trends in Pharmacolo... 2005
Schifano F, Corkery J, Oy... Trapped in the 'K-hole': overview of deaths associated with ketamine m... J Clin Psychopharmac... 2008
Cottrell AM, Ayres R, Wei... Urinary tract disease associated with chronic ketamine use BMJ 2008
Shahani R, Stewart RJ Reply to letter-to-the-editor, Re: Shahani R, Streutker C, Dickson B, ... Urology 2008
Grégoire MC, MacLellan DL... A pediatric case of ketamine-associated cystitis Letter-to-the-Editor ... Urology 2008
Erowid E 2008 Behrman article: Luck of the draw: common adulterants found in il... J Emerg Nurs 2010
Fisk JE, Murphy PN, Montg... Comment on Halpern et. al (2011) Addiction 2011
Halpern JH, Sherwood AR, ... Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) Addiction 2011
Ward J, Rhyee S, Plansky ... Methoxetamine: a novel ketamine analog and growing health-care concern Clin Toxicol (Phila) 2011
Bouso JC, González D, Fon... Personality, Psychopathology, Life Attitudes and Neuropsychological Pe... PLoS ONE 2012
Weerts A, Pattyn N, Van d... Evaluation of the effects of anti-motion sickness drugs on subjective ... J Psychopharmacol 2013
O'Connell CW, Sadler CA, ... Overdose of etizolam: the abuse and rise of a benzodiazepine analog Ann Emerg Med 2015
Angerer V, Franz F, Schwa... Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabin... J Anal Toxicol 2016
Stoller A, Dolder PC, Bod... Mistaking 2C-P for 2C-B: What a Difference a Letter Makes J Anal Toxicol 2016
Green TC, Gilbert M Counterfeit Medications and Fentanyl JAMA Intern Med 2016
Dziadosz M, Klintschar M,... Postmortem concentration distribution in fatal cases involving the syn... Int J Legal Med 2017